| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.AUTREV.2014.12.006 |
| P698 | PubMed publication ID | 25534016 |
| P2093 | author name string | Cristina Belizna | |
| P433 | issue | 4 | |
| P921 | main subject | hydroxychloroquine | Q421094 |
| P304 | page(s) | 358-362 | |
| P577 | publication date | 2014-12-19 | |
| P1433 | published in | Autoimmunity Reviews | Q15754966 |
| P1476 | title | Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome | |
| P478 | volume | 14 |
| Q38845570 | Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit? |
| Q98566674 | Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q92118099 | Dermatologists' Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study |
| Q36126483 | Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus |
| Q38782057 | Emerging Therapies in Antiphospholipid Syndrome |
| Q38737387 | Endosomal Redox Signaling in the Antiphospholipid Syndrome |
| Q92711738 | Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism |
| Q39031764 | Hydroxychloroquine in systemic lupus erythematosus (SLE). |
| Q33425472 | Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report |
| Q50640109 | Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up. |
| Q98181529 | Management of anticoagulant-refractory thrombotic antiphospholipid syndrome |
| Q35622999 | Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target |
| Q39440991 | New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus. |
| Q89986376 | Pediatric APS: State of the Art |
| Q91715407 | Pediatric antiphospholipid syndrome |
| Q38891094 | Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. |
| Q35877606 | Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis |
| Q57603185 | Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case–control study |
| Q59807283 | The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome |
| Q94672281 | The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? |
| Q93020058 | The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS |
| Q33443797 | Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study |
Search more.